Sivro A. McKinnon LR, Yende-Zuma N, Gengiah S, Samsunder N, Abdool Karim SS, Naidoo K.
Clinical Infectious Diseases 2017; 65(5): 819-826.
Ngandu NK, Carlson JM, Chopera DR, Ndabambi N, Abdool Karim Q, Abdool Karim S, Williamson C.
JAIDS 2017; 76(1):43-47.
Akullian A, Bershteyn A, Klein D, Vandormael A, Bärnighausen T, Tanser F.
AIDS 2017; 31(12):1755-1764.
Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, Sawry S, Amorissani-Folquet M, Noguera-Julian A, Tanser F, Eboua F.
International Journal of Epidemiology 2017; 46(2):453-465.
Tomita A, Vandormael AM, Cuadros D, Slotow R, Tanser F, Burns JK.
Social Psychiatry and Psychiatric Epidemiology 2017; 52(8): 1023-1030.
McIvor A, Koornhof H, Kana BD.
Pathogens and Disease 2017; 75(3): 1-16. doi: 10.1093/femspd/ftx020.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.